Kymera Therapeutics
Kevin Scott is a seasoned professional in the field of pharmacology and toxicology, currently serving as Director of Non Clinical Safety at Kymera Therapeutics since February 2022, after advancing from Associate Director and Non Clinical Study Manager. Previous experience includes roles at Omeros Corporation as Non Clinical Toxicology Study Monitor, and Provetica Animal Health as In Vivo Study Manager, where responsibilities encompassed report editing, data compilation, and study management for generic drug candidates. Additional notable positions include Scientist at MRIGlobal, Research and Development Manager at Parnell Veterinary Pharmaceuticals, and Senior Scientist at Merck, along with early career experience as a Research Associate at NPS Pharmaceuticals. Kevin Scott holds a Master's degree in Pharmacology and Toxicology from Michigan State University and a Bachelor's degree in Zoology and Physiology from the University of Wyoming.
This person is not in any teams
Kymera Therapeutics
5 followers
Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.